Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,501,249,007
+$282,982,371 QoQ
Shares Held
9,939,791
-2.5% QoQ
Ownership
0.562%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#27
of 4,145 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VANGUARD FIDUCIARY TRUST CO holds $19,374,952,210 across 13 Drug Manufacturers - General names. ABBV ranks #4 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,592,311 | $5,508,156,041 | |
| 2 | JNJ |
Johnson & Johnson
|
13,517,070 | $3,432,930,267 | |
| 3 | AZN |
Astrazeneca PLC
|
13,291,085 | $2,520,255,537 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
9,939,791 | $2,501,249,007 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,869,309 | $1,782,206,206 | |
| 6 | AMGN |
Amgen Inc
|
3,080,875 | $1,115,646,455 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,972,027 | $880,845,891 | |
| 8 | PFE |
Pfizer Inc
|
32,005,869 | $770,701,325 |
All Filings in ABBV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,501,249,007 | 9,939,791 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,218,266,636 | 10,199,396 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||